Domestic Animal Endocrinology
Volume 24, Issue 1 , Pages 81-93 , January 2003

Effect of differentiation on levels of insulin-like growth factor binding protein mRNAs in cultured porcine embryonic myogenic cells

  • B.J Johnson

      Affiliations

    • Department of Animal Sciences and Industry, Kansas State University, Manhattan, KS 66506, USA
    • ,
  • M.E White

      Affiliations

    • Animal Growth and Development Laboratory, Department of Animal Science, University of Minnesota, St. Paul, MS 55108, USA
    • ,
  • M.R Hathaway

      Affiliations

    • Animal Growth and Development Laboratory, Department of Animal Science, University of Minnesota, St. Paul, MS 55108, USA
    • ,
  • W.R Dayton

      Affiliations

    • Animal Growth and Development Laboratory, Department of Animal Science, University of Minnesota, St. Paul, MS 55108, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1-612-624-2234; fax: +1-612-624-3677.

References 

  1. Conover CA. Potentiation of insulin-like growth factor (IGF) action by IGF-binding protein-3: studies of underlying mechanism. Endocrinology. 1992;130:3191–3199
  2. Conover CA, Clarkson JT, Bale LK. Factors regulating insulin-like growth factor-binding protein-3 binding, processing, and potentiation of insulin-like growth factor action. Endocrinology. 1996;137:2286–2292
  3. Jones JI, Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 1995;16:3–34
  4. Oh Y, Müller HL, Lamson G, Rosenfeld RG. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells. Cell surface binding and growth inhibition. J. Biol. Chem. 1993;268:14964–14971
  5. Oh Y, Gucev Z, Ng L, Muller HL, Rosenfeld RG. Antiproliferative actions of insulin-like growth factor binding protein (IGFBP)-3 in human breast cancer cells. Prog. Growth Factor Res. 1995;6:503–512
  6. McCusker RH, Camacho-Hübner C, Clemmons DR. Identification of the types of insulin-like growth factor-binding proteins that are secreted by muscle cells in vitro. J. Biol. Chem. 1989;264:7795–7800
  7. Silverman LA, Cheng Z, Hsiao D, Rosenthal SM. Skeletal muscle cell-derived insulin-like growth factor (IGF) binding proteins inhibit IGF-1-induced myogenesis in rat L6E9 cells. Endocrinology. 1995;136:720–726
  8. James PL, Jones SB, Busby WH, Clemmons DR, Rotwein P. A highly conserved insulin-like growth factor-binding protein (IGFBP-5) is expressed during myoblast differentiation. J. Biol. Chem. 1993;268:22305–22312
  9. Tollefsen SE, Sadow JL, Rotwein P. Coordinate expression of insulin-like growth factor II and its receptor during muscle differentiation. Proc. Natl. Acad. Sci. USA. 1989;86:1543–1547
  10. Ernst CW, McCusker RH, White ME. Gene expression and secretion of insulin-like growth factor-binding proteins during myoblast differentiation. Endocrinology. 1992;130:607–615
  11. Ewton DZ, Florini JR. IGF binding proteins-4, -5 and -6 may play specialized roles during L6 myoblast proliferation and differentiation. J. Endocrinol. 1995;144:539–553
  12. Hembree JR, Pampusch MS, Yang F, Causey JL, Hathaway MR, Dayton WR. Cultured porcine myogenic cells produce insulin-like growth factor binding protein-3 (IGFBP-3) and transforming growth factor beta-1 stimulates IGFBP-3 production. J. Anim. Sci. 1996;74:1530–1540
  13. Johnson BJ, White ME, Hathaway MR, Dayton WR. Decreased steady-state insulin-like growth factor binding protein-3 (IGFBP-3) mRNA level is associated with differentiation of cultured porcine myogenic cells. J. Cell. Physiol. 1999;179:237–243
  14. Yang F, Johnson BJ, White ME, Hathaway MR, Dayton WR. Effect of insulin-like growth factor (IGF)-I and Des (1-3) IGF-I on the level of IGF binding protein-3 and IGF binding protein -3 mRNA in cultured porcine embryonic muscle cells. J. Cell. Physiol. 1999;178:227–234
  15. Hembree JR, Hathaway MR, Dayton WR. Isolation and culture of porcine myogenic cells and the effect of insulin, IGF-1 and sera on protein turnover in porcine myotube cultures. J. Anim. Sci. 1991;69:3241–3250
  16. Pampusch MS, Hembree JR, Hathaway MR, Dayton WR. Effect of transforming growth factor beta on proliferation of L6 and embryonic porcine myogenic cells. J. Cell. Physiol. 1990;143:524–528
  17. Dodson MV, Mathison BA, Hossner KL. Interaction of ovine somatomedin-c/IGF-I and IGF-I with specific IGF-I receptors on cultured muscle-derived fibroblasts. Acta Endocrinol. 1987;116:186–192
  18. Hathaway MR, Pampusch MS, Hembree JR, Dayton WR. Transforming growth factor beta-1 facilitates establishing clonal populations of ovine muscle satellite cells. J. Anim. Sci. 1994;72:2001–2007
  19. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction. Anal. Biochem. 1987;162:156–159
  20. Wright WE, Sassoon DA, Lin VK. Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell. 1989;56:607–617
  21. Shimasaki S, Shimonaka M, Ui M, Inouye S, Shibata F, Ling N. Structural characterization of a follicle-stimulating hormone action inhibitor in porcine ovarian follicular fluid. Its identification as the insulin-like growth factor-binding protein. J. Biol. Chem. 1990;265:2198–2202
  22. Tseng LYH, Brown AL, Yang YWH, Romanus JA, Orlowski CC, Taylor T, et al. The fetal rat binding protein for insulin-like growth factors is expressed in the choroid plexus and cerebrospinal fluid of adult rats. Mol. Endocrinol. 1989;3:1559–1568
  23. Shimasaki S, Shimonaka M, Zhang H-P, Ling N. Isolation and molecular characterization of three novel insulin-like growth factor binding proteins (IGFBP-4, 5 and 6). In: Spencer EM, editor. Modern concepts of insulin-like growth factors. New York: Elsevier; 1991, p. 343-58.
  24. Florini JR, Ewton DZ, Roof SL. Insulin-like growth factor-I stimulates terminal myogenic differentiation by induction of myogenin gene expression. Mol. Endocrinol. 1991;5:718–724
  25. Brown EJ, Hsiao D, Rosenthal SM. Induction and peak gene expression of insulin-like growth factor II follow that of myogenin during differentiation of BC3H-1 muscle cells. Biochem. Biophys. Res. Commun. 1992;183:1084–1089
  26. Rosen KM, Wentworth BM, Rosenthal N, Villa-Komaroff L. Specific, temporally regulated expression of the insulin-like growth factor II gene during muscle cell differentiation. Endocrinology. 1993;133:474–481
  27. Tollefsen SE, Lajara R, McCusker RH, Clemmons DR, Rotwein P. Insulin-like growth factors (IGF) in muscle development. Expression of IGF-I, the IGF-I receptor, and an IGF binding protein during myoblast differentiation. J. Biol. Chem. 1989;264:13810–13817
  28. Rotwein P, James PL, Kou K. Rapid activation of insulin-like growth factor binding protein-5 gene transcription during myoblast differentiation. Mol. Endocrinol. 1995;9:913–923
  29. James PL, Stewart CEH, Rotwein P. Insulin-like growth factor binding protein-5 modulates muscle differentiation through an insulin-like growth factor-dependent mechanism. J. Cell. Biol. 1996;133:683–693
  30. Dong F, Wu HB, Hong J, Rechler MM. Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-beta in mink lung epithelial cells. J. Cell. Physiol. 2002;190:63–73
  31. Hoeflich A, Nedbal S, Blum WF, Erhard M, Lahm H, Brem G, et al.  Growth inhibition in giant growth hormone transgenic mice by overexpression of insulin-like growth factor-binding protein-2. Endocrinology. 2001;142:1889–1898
  32. Clemmons DR. Role of insulin-like growth factor binding proteins in controlling IGF actions. Mol. Cell. Endocrinol. 1998;140:19–24
  33. Oh Y. IGFBPs and neoplastic models. New concepts for roles of IGFBPs in regulation of cancer cell growth. Endocrine. 1997;7:111–113
  34. Firth SM, Ganeshprasad U, Baxter RC. Structural determinants of ligand and cell surface binding of insulin-like growth factor-binding protein-3. J. Biol. Chem. 1998;273:2631–2638
  35. Oh Y. IGF-independent regulation of breast cancer growth by IGF binding proteins [in process citation]. Breast Cancer Res. Treat. 1998;47:283–293
  36. Oh Y, Muller HL, Pham H, Rosenfeld RG. Demonstration of receptors for insulin-like growth factor binding protein-3 on Hs578T human breast cancer cells. J. Biol. Chem. 1993;268:26045–26048
  37. Valentinis B, Bhala A, DeAngelis T, Baserga R, Cohen P. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol. Endocrinol. 1995;9:361–367
  38. Nickerson T, Huynh H, Pollak M. Insulin-like growth factor binding protein-3 induces apoptosis in MCF7 breast cancer cells. Biochem. Biophys. Res. Commun. 1997;237:690–693
  39. Oh Y, Müller HL, Ng L, Rosenfeld RG. Transforming growth factor-β-induced cell growth inhibition in human breast cancer cells is mediated through insulin-like growth factor-binding protein-3 action. J. Biol. Chem. 1995;270:13589–13592
  40. Leal SM, Liu Q, Huang SS, Huang JS. The type V transforming growth factor beta receptor is the putative insulin-like growth factor-binding protein 3 receptor. J. Biol. Chem. 1997;272:20572–20576
  41. Fanayan S, Firth SM, Butt AJ, Baxter RC. Growth inhibition by insulin-like growth factor-binding protein-3 in T47D breast cancer cells requires transforming growth factor-beta (TGF-beta ) and the type II TGF-beta receptor. J. Biol. Chem. 2000;275:39146–39151
  42. Fanayan S, Firth SM, Baxter RC. Signaling through the Smad pathway by insulin-like growth factor-binding protein-3 in breast cancer cells. Relationship to transforming growth factor-beta 1 signaling. J. Biol. Chem. 2002;277:7255–7261

☆ Published as paper no. of the scientific journal series of the Minnesota Agric. Exp. Sta. on research conducted under Minnesota Agric. Exp. Sta. project no. 16-084.

PII: S0739-7240(02)00207-2

Domestic Animal Endocrinology
Volume 24, Issue 1 , Pages 81-93 , January 2003

Article Tools

* Image Usage & Resolution